SREBF2 and early-onset autosomal dominant Alzheimer disease: In early works, using APPswe/PSEN1dE1 mice overexpressing the sterol regulatory element-binding transcription factor 2 (SREBF2), we demonstrated that elevated brain cholesterol levels accelerate and worsen the pathological features of Alzheimer’s disease, including neuroinflammation [153].